drugset / Trial / NCT04519879
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
RandomizedCrossoverOpen-labelTreatment
Summary
This phase II trial studies how well white button mushroom supplement works in reducing prostate-specific antigen (PSA) levels in patients with prostate cancer that has come back (recurrent) or has favorable risk and has not undergone any therapy (therapy naive). PSA is a blood marker of prostate growth. White button mushroom supplement may affect PSA level, various parameters of immune system and levels of hormones that may have a role in prostate cancer growth.
Timeline
- Start
- 2021-05-10
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
Outcome
Outcome not reported
Stopped: “05/26/2026 DSMC: Delinquent PMT reporting.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | White Button Mushroom Extract | Other / unclassified | — | Oral |